KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Receivables (2016 - 2026)

Staar Surgical's Receivables history spans 17 years, with the latest figure at $50.4 million for Q1 2026.

  • For Q1 2026, Receivables fell 52.15% year-over-year to $50.4 million; the TTM value through Jan 2026 reached $50.4 million, down 52.15%, while the annual FY2026 figure was $50.4 million, 52.15% down from the prior year.
  • Receivables reached $50.4 million in Q1 2026 per STAA's latest filing, down from $60.1 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $112.4 million in Q3 2023 to a low of $34.4 million in Q2 2025.
  • Average Receivables over 5 years is $71.6 million, with a median of $63.2 million recorded in 2022.
  • Peak YoY movement for Receivables: skyrocketed 102.72% in 2023, then plummeted 63.28% in 2025.
  • A 5-year view of Receivables shows it stood at $62.5 million in 2022, then surged by 51.64% to $94.7 million in 2023, then rose by 11.32% to $105.4 million in 2024, then plummeted by 42.99% to $60.1 million in 2025, then dropped by 16.07% to $50.4 million in 2026.
  • Per Business Quant, the three most recent readings for STAA's Receivables are $50.4 million (Q1 2026), $60.1 million (Q3 2025), and $34.4 million (Q2 2025).